Wendy's rejects $1.4 billion buyout offer
The board turned down a $7.35 per share bid from Trian Partners and others.

The short version
- Wendy's adopted a poison pill to block future hostile takeovers.
- Shares rose to $7.94 on November 5 following the rejection.
Wendy's has officially rejected an unsolicited $1.4 billion acquisition proposal from a group led by Trian Partners, Flynn Group LP, BlueFive Capital, and Sixth Street Partners. The offer of $7.35 per share in cash was dismissed by an independent committee, which stated the bid substantially undervalues the company.
Wendy's board also adopted a poison pill, a defensive measure designed to make hostile takeovers more difficult for outside investors. The offer represented a 20% premium over the company's share price as of October 27. On November 5, the day the rejection was announced, the stock price climbed as high as $8.03 before closing at $7.94.
Art Winkleblack, the chairman of the board, expressed full confidence in CEO Bob Wright and his plan to improve profitability through a new initiative called Dave's way. This strategy focuses on growing customer traffic and strengthening digital operations across the chain's 7,000 global locations.
Wendy's recently reported a 66% drop in third-quarter net income to $15.1 million, with total revenue dipping slightly to $547 million. The company maintains that its current leadership team is better positioned to deliver long-term value than the proposed buyout. Apparently.
About Wendy's
American international fast food chain restaurant
- Share price
- $8.28+1.22% last trading day
- Founded
- 1969by Dave Thomas
- Based in
- Dublin
- Owned by
- ShareholdersNasdaq: WEN
From Wikipedia and Yahoo Finance. Figures can be a year or two old.




